ArticleBMC cardiovascular disorders2026
Risk factors for diuretic resistance in hospitalized patients with acute decompensated heart failure: a retrospective study.
Article in BMC cardiovascular disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo investigate the independent risk factors for diuretic resistance (DR) and its clinical impact in hospitalized patients with acute decompensated heart failure (ADHF).
methodsThis single-center retrospective study consecutively enrolled 387 patients with ADHF admitted between January 2022 and June 2025. Based on an operational definition (intravenous furosemide ≥ 80 mg/day with failure to achieve an average daily body weight reduction ≥ 1 kg or a net negative fluid balance ≥ 1,000 mL within 72 h), patients were classified into a DR group (n = 132) and a non-DR group (n = 255). Demographic characteristics, comorbidities, laboratory parameters at admission, and medication history were collected and compared between groups. Multivariable logistic regression analysis (backward stepwise method) was performed to identify independent risk factors for DR, and receiver operating characteristic (ROC) curves were used to evaluate the predictive performance of identified factors. A nomogram was then constructed to visualize the combined predictive model.
resultsThe incidence of DR among patients with ADHF was 34.11%. Nonsteroidal anti-inflammatory drug (NSAID) use within one week prior to admission, chronic kidney disease stage 3, and New York Heart Association (NYHA) functional class III-IV were independent risk factors for DR. Higher serum sodium levels, estimated glomerular filtration rate (eGFR), and serum albumin levels were identified as protective factors. Log-transformed and standardized N-terminal pro-B-type natriuretic peptide (NT-proBNP) was a very strong predictor of DR. Using the Youden index, the optimal cutoff value of baseline NT-proBNP for predicting DR was 1,003.19 pg/mL (sensitivity 81.06%, specificity 80.39%).
conclusionNT-proBNP and eGFR demonstrate good predictive value for DR. The occurrence of DR is significantly associated with prolonged hospitalization and an increased risk of renal function deterioration.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.